break
toler
unrespons
selfantigen
involv
activ
autoreact
lymphocyt
critic
event
lead
autoimmun
diseas
precis
mechan
occur
mostli
unknown
virus
implic
process
among
etiolog
factor
genet
predisposit
cytokin
activ
sever
way
propos
viral
infect
might
break
toler
self
trigger
autoreact
cascad
ultim
lead
destruct
specif
cell
type
entir
organ
process
term
molecular
mimicri
use
transgen
model
viral
host
gene
manipul
analyz
effect
caus
autoimmun
particular
focus
research
exampl
transgen
murin
model
virusinduc
autoimmun
diseas
known
viral
gene
select
express
selfantigen
cell
pancrea
mice
insulindepend
diabet
develop
either
viral
infect
releas
cytokin
ifni
express
costimulatori
molecul
islet
langerhan
recent
studi
use
model
contribut
understand
pathogenesi
virusinduc
autoimmun
diseas
further
design
test
novel
immunotherapeut
approach
abbrevi
apc
antigenpres
cell
cmv
cytomegaloviru
ctl
cytotox
lymphocyt
gp
glycoprotein
iddm
insulindepend
diabet
type
ii
ifn
interferon
il
interleukin
lcmv
lymphocyt
choriomening
viru
mbp
myelin
basic
protein
ms
multipl
sclerosi
np
nucleoprotein
rip
rat
insulin
promot
tcr
cell
receptor
autoimmun
disord
human
character
break
immunolog
toler
selfantigen
mani
autoimmun
diseas
involv
specif
target
cell
organ
pancreat
cell
destroy
insulindepend
diabet
type
iddm
destruct
axon
myelin
sheath
multipl
sclerosi
ms
although
patholog
pictur
well
document
knowledg
precis
etiolog
trigger
autoimmun
process
mechan
pathogenesi
initi
selfantigen
involv
still
vagu
mani
instanc
autoantibodi
autoreact
cell
found
preced
onset
clinic
diseas
sever
year
exampl
antibodi
glutam
decarboxylas
islet
cell
protein
detect
prediabet
individu
open
possibl
detect
earli
selfantigen
may
involv
autoimmun
process
design
specif
therapeut
approach
prevent
develop
diseas
even
destruct
process
start
two
new
strategi
oral
toler
induct
use
mhc
class
restrict
peptid
modul
autoreact
immun
respons
shown
promis
regard
virus
infecti
agent
implic
autoimmun
basi
sever
find
first
although
autoimmun
diseas
associ
one
multipl
host
gene
environment
factor
also
play
role
support
concept
come
studi
perform
monozygot
twin
exampl
although
studi
link
sever
haplotyp
mhc
increas
risk
either
iddm
ms
incid
ms
iddm
shown
vari
monozygot
twin
also
depend
geograph
locat
lifestyl
henc
autoimmun
diseas
muhifactori
etiolog
second
autoimmun
respons
autoimmun
diseas
newli
gener
enhanc
infect
varieti
human
dna
rna
virus
human
experiment
anim
antibodi
dna
rna
red
blood
cell
elicit
new
zealand
white
nzw
mice
level
enorm
enhanc
new
zealand
black
nzb
nzb
nzw
mice
persist
infect
dna
viru
polyomaviru
rna
viru
lymphocyt
choriomening
viru
lcmv
superantigen
also
implic
trigger
autoimmun
respons
one
potenti
mechan
wherebi
virus
could
caus
autoimmun
molecular
mimicri
virus
well
microbi
agent
may
possess
protein
structur
shape
mimic
normal
host
selfprotein
immun
respons
elicit
pathogen
elimin
also
crossreact
one
selfantigen
share
determin
agent
immunopatholog
process
could
continu
chronic
reiniti
multipl
viral
infect
henc
diseas
could
continu
trigger
agent
elimin
ie
presenc
longer
detect
hit
run
phenomenon
evid
crossreact
immun
respons
virusesmicrob
selfantigen
note
mani
investig
influenc
host
genet
factor
suscept
autoimmun
diseas
taken
account
well
molecular
mimicri
sinc
host
gene
control
immun
respons
variou
infecti
agent
play
role
express
viral
receptor
influenc
viral
replic
major
difficulti
establish
correl
trigger
event
viral
infect
actual
autoimmun
diseas
usual
long
lag
period
often
preced
clinic
onset
diseas
make
recoveri
viru
microb
difficult
later
autoimmun
diseas
develop
circumv
part
difficulti
allow
detail
analysi
kinet
develop
diseas
transgen
technolog
employ
place
viral
gene
specif
cell
interest
cell
oligodendrocyt
etc
use
tissuespecif
promot
foreign
viral
microbi
gene
integr
host
gene
pass
progeni
essenc
becom
selfantigen
allow
critic
assess
immun
respons
cellular
factor
cytokin
play
role
break
toler
selfmark
protein
therebi
caus
autoimmun
diseas
addit
model
serv
use
tool
develop
test
novel
therapeut
approach
critic
evalu
role
selfantigen
autoimmun
process
review
provid
recent
data
gather
vitro
vivo
illustr
virus
trigger
autoimmun
diseas
concept
understand
pathogenesi
virusinduc
autoimmun
diseas
well
novel
immunotherapeut
approach
discuss
induct
develop
autoimmun
process
involv
break
toler
unrespons
selfantigen
present
peripheri
although
vast
major
cell
bear
tcr
high
affin
selfantigen
elimin
develop
thymu
process
term
neg
select
naiverest
precursor
potenti
autoreact
cell
loweraffin
tcr
escap
select
process
travel
peripheri
cell
activ
normal
condit
virus
cours
infect
induc
releas
multipl
cytokin
ifni
induc
elev
level
mhc
class
class
ii
express
tough
borrow
sprent
shown
memori
cell
prolifer
initi
releas
type
interferon
ifnot
virus
also
polyclon
activ
lymphocyt
includ
potenti
autoreact
lymphocyt
effector
cell
cross
react
potenti
selfantigen
along
line
infect
one
viru
activ
memori
lymphocyt
gener
respons
earlier
differ
viral
infect
certain
popul
crossactiv
cell
may
potenti
autoreact
abl
induc
autoimmun
diseas
multipl
exampl
either
antibodi
cell
crossreact
selfantigen
individu
autoimmun
diseas
review
exampl
dan
kaufman
colleagu
provid
evid
associ
coxsacki
viru
protein
glutam
reactiv
onset
autoimmun
diabet
mellitu
human
recent
exampl
crossreact
abnorm
immun
respons
virus
selfprotein
describ
rheumatoid
arthriti
celiac
diseas
primari
biliari
cirrhosi
myocard
system
lupu
erythematosu
ms
among
virus
implic
autoimmun
epsteinbarr
viru
human
lymphotrop
viru
type
hepat
c
viru
cytomegaloviru
cmv
hiv
corona
virus
mump
coxsacki
furthermor
epidemiolog
evid
link
rubella
cmv
coxsacki
virus
cluster
iddm
case
predict
potenti
crossreact
sequenc
match
protein
andor
peptid
addit
linear
sequenc
homolog
conform
consider
need
taken
account
instanc
one
amino
acid
substitut
nine
amino
acid
peptid
complet
abrog
bind
mhc
recognit
tcr
comput
model
inform
obtain
crystalstructur
analysi
facilit
studi
eleg
studi
wucherpfennig
stroming
evalu
crossreact
known
myelin
basic
protein
mbp
reactiv
tcell
clone
deriv
ms
patient
use
computerpredict
peptid
varieti
virus
herp
simplex
viru
epsteinbarr
viru
adenoviru
influenza
viru
one
bacterium
infect
human
pseudomona
aeruginosa
peptid
select
basi
primari
secondari
structur
would
fit
hladr
mhc
groov
data
show
peptid
abl
bind
caus
prolifer
clonal
mbpreactiv
cell
affin
either
greater
equival
known
mbp
peptid
thu
singl
tcr
capac
activ
peptid
five
differ
exogen
sourc
one
selfpeptid
studi
cell
line
establish
ms
patient
reactiv
mbp
sequenc
human
respiratori
coronaviru
addit
molecular
mimicri
human
transa
dolas
brain
express
select
oligodendrocyt
gag
protein
also
describ
human
transaldolas
stimul
prolifer
peripher
blood
lymphocyt
patient
ms
addit
autoantibodi
human
transaldolas
detect
serum
cerebrospin
fluid
patient
thu
molecular
mimicri
virus
oligodendrocyt
protein
may
import
etiolog
human
central
nervou
system
autoimmun
diseas
ms
ray
welsh
colleagu
found
memori
cell
reactiv
one
viru
activ
virus
investig
show
repeat
viral
infect
even
differ
unrel
virus
stimul
activ
memori
lymphocyt
produc
respons
previou
viral
infect
work
suggest
memori
lymphocyt
may
activ
easili
express
differ
tcr
repertoir
naiv
lymphocyt
loweraffin
tcr
therebi
facilit
crossactiv
exampl
virusinduc
autoimmun
oligodendrocyt
diseas
recent
establish
evan
et
al
cf
evan
ms
horwitz
mv
hobb
mba
oldston
unpublish
data
model
nucleoprotein
np
glycoprotein
gp
lcmv
express
oligodendrocyt
use
mbp
promot
replic
lcmv
given
parenter
lcmvspecif
lymphocyt
predominantli
also
activ
peripheri
cross
bloodbrain
barrier
enter
central
nervou
system
caus
diseas
find
welsh
cowork
central
nervou
system
diseas
enhanc
lcmv
pichind
vaccinia
virus
administ
sequenti
interv
six
week
sever
month
slowonset
iddm
induct
slowonset
rapidonset
iddm
lcmv
riplcmv
transgen
mice
slowonset
iddm
occur
mous
line
thymic
express
viral
self
antigen
depend
lymphocyt
transgen
mice
slowonset
iddm
develop
islet
infiltr
earli
seven
day
lcmv
infect
isletinfiltr
lymphocyt
predominantli
found
around
islet
insid
islet
periinsul
persist
six
month
ripnp
b
mice
lymphocyt
found
around
islet
produc
thl
cytokin
approxim
six
month
post
lcmv
infect
cytokin
profil
switch
rather
suddenli
thl
associ
infiltr
islet
develop
iddm
one
two
week
switch
occur
rapidonset
iddm
occur
line
without
thymic
express
depend
ctl
wherea
inocul
pichind
vaccinia
virus
absenc
lcmv
challeng
caus
diseas
number
transgen
anim
model
creat
studi
pathogenesi
autoimmun
diseas
model
influenc
environment
factor
pathogen
discov
serendipit
incid
spontan
autoimmun
diseas
increas
transgen
mice
hous
quarter
free
specif
pathogen
presenc
natur
occur
bacteria
andor
viral
flora
exampl
hammer
taurog
colleagu
gener
transgen
rat
spontan
develop
autoimmun
syndrom
resembl
ankylos
spondyl
rat
transfer
germfre
condit
sign
diseas
disappear
similarli
tcrtransgen
model
experiment
allerg
encephalomyel
resembl
ms
develop
goverman
colleagu
incid
experiment
autoimmun
encephalomyel
increas
pathogencontain
room
present
neither
model
precipit
agent
event
known
laboratori
specif
gener
transgen
model
studi
role
infect
autoimmun
diseas
model
use
rat
insulin
promot
rip
express
lcmv
protein
lcell
islet
langerhan
proven
inform
transgen
mice
engin
independ
laboratori
hengartn
zinkernagel
neither
case
transgen
mice
develop
iddm
immunopatholog
islet
unless
infect
lcmv
mice
develop
iddm
riplcmv
transgen
model
come
two
flavor
first
viral
transgen
express
islet
langerhan
iddm
follow
lcmv
challeng
develop
rapidli
nearli
destroy
within
two
week
antilcmv
self
lymphocyt
mandatori
gener
iddm
deplet
lymphocyt
antibodi
cross
rapidonset
iddm
mice
background
lack
gene
result
abrog
iddm
indic
islet
destroy
cytotox
lymphocyt
ctl
either
directli
indirectli
determin
whether
direct
kill
ctl
depend
perforin
pathway
iddm
riplcmv
transgen
mice
studi
mice
perforin
gene
knock
absenc
function
perforin
gene
iddm
occur
factor
howev
cytokin
also
involv
process
perforin
cell
necessari
destruct
exampl
perforincompet
ctl
present
riplcmv
mice
destruct
occur
absenc
indic
destruct
lcell
muitifactori
process
unpublish
data
addit
perforinmedi
kill
lysi
observ
perforinindepend
fa
pathway
direct
kill
pathway
known
indirect
bystand
death
pcell
secret
cytokin
factor
worthi
futur
investig
second
type
riplcmv
model
slowli
progress
injuri
produc
iddm
within
six
month
viral
infect
delay
iddm
occur
depend
mhc
background
mice
develop
iddm
within
two
month
b
mice
requir
three
six
month
slowonset
iddm
mice
viral
transgen
express
pancrea
thymu
tissu
transgen
express
thymu
highaffin
antiself
viral
ctl
elimin
neg
select
lowaffin
antiself
ctl
escap
thymic
neg
select
traffic
peripheri
identifi
islet
infiltr
confirm
expand
find
lcmv
antigen
purpos
express
transgen
thymu
use
thymusspecif
promot
transgen
mice
also
remov
highaffin
antilcmv
self
ctl
lowaffin
cell
pass
peripheri
support
propos
model
affin
depend
thymic
posit
neg
select
riplcmv
model
illustr
figur
deplet
andor
lymphocyt
use
monoclon
antibodi
show
although
cell
requir
induc
iddm
transgen
line
fastonset
iddm
requir
slowonset
line
highaffin
cell
delet
henc
lowaffin
antilcmv
self
ctl
need
cell
gener
iddm
although
cell
test
vitro
lyse
lcmvinfect
target
cell
directli
studi
show
express
viral
self
antigen
thymu
suffici
induc
complet
toler
slowli
progress
autoimmun
process
trigger
lowaffin
ctl
escap
neg
select
becom
activ
memori
cell
react
lcmv
antigen
might
requir
local
drive
autoimmun
process
autoreact
ctl
lower
affin
known
whether
infiltr
lymphocyt
found
insul
lesion
mainli
naiv
memori
phenotyp
mani
fulli
activ
studi
shown
gener
mainten
memori
ctl
impair
absenc
lymphocyt
lowaffin
selfreact
ctl
demonstr
riplcmv
transgen
model
also
found
transgen
model
ofautoimmun
diseas
viral
infect
viral
infect
induc
highaffin
ctl
import
viral
clearanc
loweraffin
ctl
respons
potenti
lowaffin
ctl
recogn
differ
viral
peptid
virus
sever
mhc
allel
henc
loweraffin
ctl
display
less
specif
highaffin
ctl
might
prone
crossreact
antigen
number
antivir
self
ctl
correl
incid
onset
autoimmun
diseas
follow
lcmv
infect
riplcmv
transgen
mice
express
transgen
cell
specif
antilcmv
ctl
gener
precursor
frequenc
approxim
primari
burst
day
post
intraperiton
infect
number
drop
frequenc
day
post
intraperiton
infect
repres
lcmvspecif
memori
ctl
present
host
instead
inocul
replic
lcmv
viru
transgen
mice
given
vaccinia
viru
recombin
express
lcmv
transgen
number
lcmvspecif
ctl
induc
log
less
iddm
occur
number
selfreact
ctl
increas
howev
cell
prolifer
local
islet
langerhan
presenc
costimulatori
molecul
cytokin
tnfot
rcell
islet
exampl
iddm
occur
infect
vaccinia
viruslcmv
recombin
thu
critic
number
activ
autoreact
ctl
need
induc
iddm
insuffici
number
ctl
iddm
develop
unless
factor
present
islet
expand
ctl
number
andor
enhanc
inflammatori
process
quantit
aspect
induct
autoimmun
diseas
also
observ
tcr
transgen
model
either
spontan
diseas
induc
incid
diseas
enhanc
cell
engin
bear
selfantigenreact
tcr
evid
concept
come
report
genain
etal
show
myelinreact
cell
isol
blood
normal
healthi
marmoset
caus
encephalomyel
activ
amplifi
vitro
infus
back
anim
caus
encephalomyel
express
lcmv
transgen
alon
lcell
use
rip
induc
autoimmun
diabet
lcmv
transgen
coexpress
howev
antiself
viral
ctl
activ
spontan
absenc
viral
infect
spontan
iddm
occur
contrast
lcmv
transgen
express
thymu
islet
express
islet
activ
antilcmv
self
ctl
iddm
occur
mice
given
challeng
lcmv
howev
rapidonset
iddm
develop
within
day
viral
challeng
contrast
singli
transgen
ripnp
litterm
iddm
develop
four
five
month
viral
challeng
rapid
iddm
associ
increas
number
antivir
self
ctl
predomin
ifntproduc
lymphocyt
islet
singli
transgen
ripnp
litterm
slowonset
iddm
fewer
antiself
ctl
made
lymphocyt
found
islet
immun
respons
believ
regul
balanc
thl
cytokin
ifni
group
thltype
cytokin
proinflammatori
effect
involv
differenti
activ
cell
natur
killer
cell
apc
ifnt
involv
antivir
defens
mechan
upregul
express
mhc
class
ii
molecul
cytokin
along
tgf
shown
inhibit
thl
cell
vitro
thought
inhibitori
effect
certain
immun
respons
vivo
ifnt
coexpress
islet
lcmv
transgen
unrespons
viral
transgen
broken
appar
lcmv
self
specif
ctl
aris
spontan
iddm
occur
without
usual
requir
lcmv
infect
contrast
ifni
gene
knock
riplcmv
mice
develop
autoimmun
diabet
mhc
molecul
upregul
islet
follow
lcmv
infect
mg
yon
herrath
mba
oldston
unpublish
data
coexpress
lcmv
transgen
cell
neither
spontan
gener
antilcmv
self
ctl
iddm
follow
despit
spontan
infiltr
cell
upregul
mhc
class
islet
cell
kinet
iddm
quicken
sever
diseas
increas
howev
riplcmvx
mice
challeng
lcmv
yet
transform
growth
coexpress
lcmv
antigen
lcell
unexpectedli
variat
incid
iddm
observ
common
theme
emerg
studi
mice
develop
iddm
lymphocyt
islet
wherea
develop
iddm
ifntand
fewer
cell
preliminari
studi
collabor
nora
sarvetnick
indic
riplcmv
transgen
mice
also
express
lcell
develop
iddm
viral
challeng
recent
express
islet
nonobes
diabet
mice
shown
prevent
iddm
find
suggest
major
immun
regulatori
role
cytokin
iddm
also
show
interest
correl
destruct
nondestruct
autoimmun
infiltr
relationship
local
cytokin
milieu
role
cytokin
remain
undetermin
point
antigenspecif
therapi
toler
antiself
cell
therebi
elimin
drive
forc
tcellmedi
autoimmun
diseas
achiev
two
differ
mechan
first
peripher
toler
induc
clonal
delet
anergi
induct
exhaust
autoreact
cell
presenc
larg
amount
selfantigen
peripheri
andor
lack
costimul
antigen
present
experiment
treatment
design
base
observ
aichel
et
al
success
prevent
iddm
riplcmvgp
transgen
mice
immun
specif
lcmvgp
peptid
treatment
result
toler
lcmv
gpspecif
ctl
second
mechan
employ
approach
bystand
suppress
immun
deviat
toler
initi
immun
antigen
induc
cell
mediat
suppress
secret
suppress
cytokin
transform
growth
factorl
idea
turn
profil
respons
target
area
immunosuppress
cytokin
made
primarili
lymphocyt
may
also
produc
cell
iymphocyt
low
dose
oral
administ
antigen
believ
favor
activ
suppress
activ
lymphocyt
wherea
higher
dose
favor
clonal
anergi
autoreact
inflammatori
thl
lymphocyt
exampl
lymphocyt
react
glutam
decarboxylas
iddm
mean
possibl
treat
organspecif
diseas
eg
iddm
pancreat
islet
even
initi
autoantigen
known
perhap
antigenspecif
regulatori
cell
activ
peyer
patch
gut
home
specif
tissu
oral
antigen
resid
natur
eg
insulin
tcell
present
apc
inflamm
ongo
consequ
local
secret
immunosuppress
cytokin
suppress
autoimmun
respons
diseas
despit
controversi
whether
therapi
work
activ
suppress
gener
transform
growth
factor
clonal
anergi
exhaust
selfreact
lymphocyt
treatment
proven
effect
varieti
tcellmedi
experiment
autoimmun
diseas
interestingli
oral
insulin
therapi
also
prevent
virusinduc
iddm
riplcmv
transgen
mice
therapi
success
begun
initi
iddm
also
effect
administ
cours
diabet
therapi
succe
model
viral
transgen
express
cell
thymu
howev
henc
work
loweraffin
antiself
viral
effector
cell
therapi
effect
transgen
express
lcell
iddm
caus
highaffin
effector
lymphocyt
final
sinc
virus
interfer
differ
level
antigenpresent
pathway
express
gene
area
target
autoimmun
activ
expect
block
autoimmun
diseas
adenovir
complex
gene
interfer
transport
mhc
class
molecul
cell
surfac
coexpress
complex
gene
specif
islet
langerhan
transgen
mice
togeth
witfh
lcmv
protein
use
rip
prevent
virusinduc
iddm
mg
von
herrath
efrat
mba
oldston
ms
horwitz
unpublish
data
herp
simplex
viru
infect
cell
protein
protein
cmv
us
uniqu
short
usll
protein
prevent
antigen
present
vitro
although
present
proof
viral
protein
interfer
antigen
present
vivo
base
transgen
model
like
scenario
sequenc
event
occur
virusinduc
autoimmun
diseas
first
peripher
unrespons
broken
activ
crossreact
probabl
lowaffin
lymphocyt
cell
home
respect
target
organ
exampl
iddm
oligodendrocyt
ms
selfantigen
recogn
respons
activ
lymphocyt
releas
cytokin
possibl
mediat
exampl
ctl
begin
kill
target
cell
bear
respect
mhc
class
peptid
complex
depend
precursor
frequenc
cell
initi
trigger
autoimmun
process
local
cytokin
milieu
mhc
background
gene
involv
autoimmun
diseas
occur
either
fast
slow
damag
probabl
mediat
either
indirectli
releas
cytokin
directli
ctlmediat
lysi
target
cell
damag
occur
chain
reaction
set
place
potenti
selfantigen
may
releas
present
profession
apc
autoimmun
respons
extend
selfantigen
target
site
sequenc
event
would
explain
occurr
autoantibodi
preced
clinic
onset
diseas
isletcel
antibodi
found
iddm
crossreact
viru
selfantigen
initi
trigger
event
subsequ
infect
differ
virus
b
x
necessarili
crossreact
selfantigen
could
activ
expand
vitu
aspecif
memori
ie
lymphocyt
thu
enhanc
diseas
sever
cf
evan
ms
horwitz
mv
hobb
mba
oldston
unpublish
data
scenario
would
explain
epidemiolog
find
associ
autoimmun
diseas
multipl
viral
infect
may
also
explain
diseas
like
ms
cerebrospin
fluid
contain
elev
gammaglobulin
level
antibodi
specif
multipl
virus
specif
antivir
therapi
inhibit
viral
replic
spread
toler
antivir
immun
respons
model
system
may
eventu
provid
guid
cure
autoimmun
diseas
virus
microbi
agent
major
contribut
factor
human
autoimmun
diseas
sever
studi
review
suggest
agent
identifi
one
would
expect
reduct
incid
autoimmun
diseas
effect
broadli
applic
antivir
therapi
becom
avail
